Stock Under $10 with 50-100% upside potential - 14 Days FREE!
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stock Under $10 that he thinks could potentially double or triple in the next 6 to 12-months. See what he's trading today with a 14-day FREE pass.

MAKO Surgical Corporation (MAKO): Today's Featured Health Services Loser

MAKO Surgical Corporation (MAKO) pushed the Health Services industry lower today making it today's featured Health Services loser. The industry as a whole closed the day up 1.6%. By the end of trading, MAKO Surgical Corporation fell 54 cents (-2.4%) to $21.63 on average volume. Throughout the day, 1.8 million shares of MAKO Surgical Corporation exchanged hands as compared to its average daily volume of 1.4 million shares. The stock ranged in price between $21.33-$22.35 after having opened the day at $22.17 as compared to the previous trading day's close of $22.17. Other company's within the Health Services industry that declined today were: Fonar Corporation (FONR), down 14.2%, D Medical Industries (DMED), down 12.3%, Dehaier Medical Systems (DHRM), down 10.4%, and Mela (MELA), down 9.2%.

MAKO Surgical Corp., a medical device company, markets its advanced robotic arm solution and orthopedic implants for orthopedic procedures in the United States and internationally. MAKO Surgical Corporation has a market cap of $966.4 million and is part of the health care sector. Shares are down 10% year to date as of the close of trading on Friday. Currently there is one analyst that rates MAKO Surgical Corporation a buy, no analysts rate it a sell, and seven rate it a hold.

TheStreet Ratings rates MAKO Surgical Corporation as a sell. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income, disappointing return on equity, weak operating cash flow and generally disappointing historical performance in the stock itself.

On the positive front, Electromed (ELMD), up 23%, Uroplasty (UPI), up 18.2%, IsoRay (ISR), up 15.3%, and Stereotaxis (STXS), up 14.5%, were all gainers within the health services industry with Medtronic (MDT) being today's featured health services industry winner.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR (XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care (RXD).

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 15,381.98 27.58 0.18%
NASDAQ 3,506.49 7.52 0.21%
S&P 500 1,670.54 3.07 0.18%
US 10 Yr 1.956% +0.007

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs